growth led mitg rtg segment emerg market
maintain buy rate upgrad tp
deriv tp base forward price-to-earnings multipl
adjust ep provid upsid
potenti estim top-
line revenu grow
estim base follow factor strong
growth mitg rtg segment strong growth across
emerg market newli launch product
medtron revenu increas
adjust neg impact foreign
currenc net incom
ep non-gaap net incom increas
non-gaap ep
revenu out-performance minim therapi
restor therapi group well broad strength
across emerg market help off-set certain market-
specif headwind face quarter
mitg revenu grew led strength
advanc energi advanc stapl respiratori renal
rtg revenu grew driven high-
teen growth neurosurgeri neurovascular emerg
market grew driven growth south asia
middl east africa low-doubl digit growth
compani name plc tickermdtstock ratingbuyunchangedindustri viewoverweightpositivepric jun week week volum volum ep margin margin ttm per share growth profit ttm ttm incom ttm earn growth plc jun
incom statement
non-
per share item
product perform develop
valuat consensu perform
cvg revenu decreas cvg
revenu perform driven mid-singl digit growth
apv csh off-set low-singl digit declin crhf
constant currenc basi
emerg technolog revenu grew low-fifti
constant currenc basi driven on-going
launch guardian connect cgm system
sugar iq person diabet assist grew tripl
digit
plc announc enter definit
agreement pursuant acquir titan spine
privately-held titanium spine interbodi implant surfac
technolog compani board director
compani unanim approv transact
current price-to-earnings averag price-to-earnings
due increas stock price price-to-earnings show
huge fluctuat last three year due volatil
stock price price-to-earnings trail
expect forward price-to-earnings
continu make progress robust excit
pipelin contain opportun growth
time compani histori
stock price histori date high obsolet date obsolet move move share statist averag volum averag volum share held held share short short share short prior month error dividend split forward annual dividend forward annual dividend trail annual dividend trail annual dividend year averag dividend pay-out dividend date apr ex-dividend date last split factor new per last split date sep inform medtron plc jun
incom statement
non-
per share item
product perform develop
valuat consensu perform
non- reconcili refer page
incom statement item total gross research develop sell gener administr sg restructur oper interest incom special interest non-oper minor incom incom incom net incom outstand dilut ep dilut ep actual annual estim annual actual quarterli plc jun
 market account receivable- total prepaid expenses- current total current build machineri furnitur total fix non-curr defer incom taxes- non-curr total non-curr total equiti liabilitiesaccount accru defer revenues- current liabilities- total current long-term defer incom non-curr minor interest total non-curr liabilities- total liabilities- prefer stock equity- common stock addit paid-in retain treasuri stock- total total total liabil stock actual annual actual quarterli balanc sheet item medtron plc jun
flow oper activ increas period compar
increas led oper margin expans increas cash collect
custom well decreas cash paid supplier vendor certain litig
payment cash paid interest retir benefit plan contribut partial off-set increas
cash paid tax
use invest activ period compar cash
provid invest activ decreas attribut sale patient
deep vein thrombosi nutrit insuffici busi
result net proce cash paid acquisit due
acquisit mazor robot
use financ activ period compar
depreciation- defer incom oper increas decreas increas decreas current assets- decreas increas payables- decreas increas current liabilities- decreas increas work non- net continu net discontinu operations- net total oper invest activitiessal properti plant equipment- purchas properti plant net invest financ activitiesissu issuanc capit repurchas capit payment financ charg discontinu financ activities- net financ net floweffect exchang rate net chang begin end plc jun
plc deliv strong quarterli result growth
revenu due growth across segment region
compar
net revenu increas compar
revenu increas organ basi
adjust neg impact foreign currenc
growth revenu due out-performance mitg rtg broad
base strength emerg market
total revenu repres compani revenu
increas report non-u develop market revenu
repres compani revenu increas
report constant currenc basi emerg market revenu
repres compani revenu increas
report constant currenc basi
cog increas compar
cog net sale increas compar
increas cog net sale driven
restructur associ cost chang product mix due strong
growth lower margin busi price pressur cog
includ restructur associ cost non-gaap
cog
cog increas
compar
gross margin compar
non-gaap gross margin
sg expens increas compar
due acquisition-rel item restructur associ
cost sg expens includ acquisition-rel item also
includ restructur associ cost non-gaap
sg expens
 expens compar
 expens sale compar
amort intang asset decreas
compar due sever patent becam
fulli amort
restructur charg compar
certain litig charg compar
oper expens net compar
decreas driven gain remeasur
hedg program chang fair valu conting consider
decreas ipr charg
oper incom increas compar
oper margin compar
non-gaap oper margin
non-oper incom expens net
compar interest expens
compar due decreas total debt
oblig averag
gross margin
compar
compar
effect tax rate compar
decreas due impact tax reform non-
tax rate compar
net incom increas compar
net loss non-gaap net incom increas
gaap ep compar non-
gaap ep increas compar
period total revenu increas
compar period total
 revenu increas compar
non-u develop market revenu increas
period compar total revenu
emerg market increas period
compar
cog rel flat period
cog net sale declin period
compar
declin due divestitur lower-margin product
conjunct divestitur patient deep vein thrombosi
nutrit insuffici busi juli
gross margin period compar
compar
increas
compar
period
compar
net incom increas
month period
compar
 expens increas period
compar expens net sale
increas period compar
sg expens increas period
compar sg expens net sale
declin period compar
declin favor affect expens
incur connect divestitur patient deep vein
thrombosi nutrit insuffici busi
period
amort intang asset declin
period compar due sever patent
becam fulli amort
restructur charg net increas period
compar certain litig charg increas
period compar
oper expens net declin
period compar
oper profit period compar
non-oper incom net
period compar
interest expens period
compar incom tax rate
month period compar
net incom increas period
compar ep
period compar
oper four segment cardiac vascular group cvg
diabet group
cvg segment contribut revenu mitg segment contribut
revenu rtg segment contribut revenu diabet segment
contribut revenu
revenu mitg
revenu rtg segment
contribut
revenu diabet
revenu
cardiac vascular group cvg cardiac vascular group segment
includ cardiac rhythm heart failur crhf coronari structur heart
csh aortic peripher vascular apv crhf contribut
segment revenu apv contribut segment revenu csh
contribut segment revenu
cardiac vascular group cvg
cvg revenu decreas compar
increas constant currenc basi cvg
revenu increas period
compar
cvg revenu perform driven mid-singl digit growth apv
csh off-set low-singl digit declin crhf constant currenc
basi cvg revenu increas period
compar
cvg revenu increas
compar cvg revenu non-u develop
market decreas compar
cvg revenu emerg market increas
compar
crhf divis develop manufactur market product
diagnosi treatment manag heart rhythm disord heart
failur product includ implant devic lead deliveri system
product treatment atrial fibril af product design
reduc surgic site infect inform system manag
patient crhf devic integr health solut busi
crhf revenu decreas compar
decreas constant currenc basi
crhf revenu flat period
compar declin due declin heart failur
includ mid-forti declin sale left ventricular assist devic
compar
increas
compar
decreas
constant currenc
cardiac vascular group cvg
compar
arrhythmia manag grew mid-singl digit constant
currenc basi driven continu uptak micra transcathet
pace azur wireless pacemak also mid-twenti
growth tyrx absorb antibacteri envelop mid-teen
growth constant currenc basi
increas led
currenc growth
valv reflect
clinic benefit
csh divis includ therapi treat coronari arteri diseas cad
heart valv disord product includ coronari stent relat
deliveri system includ line balloon angioplasti cathet guid
cathet guid wire diagnost cathet accessori well
product repair replac heart valv perfus system
posit stabil system beat heart revascular
surgeri surgic ablat product
csh revenu increas compar
csh revenu increas
month period compar
increas led mid-teen constant currenc growth
transcathet aortic valv reflect clinic benefit
coronari growth flat constant currenc basi driven mid-teen
growth guid cathet low-doubl digit growth coronari balloon
off-set mid-singl digit declin drug-elut stent constant
cardiac vascular group cvg
apv divis consist line product therapi treat aortic
diseas aneurysm dissect transect well
peripher vascular diseas pvd critic limb ischemia
coat balloon stent angioplasti system carotid embol
protect system treatment vascular diseas outsid heart
product line includ rang endovascular stent graft
accessori includ endur abdomin aortic aneurysm aaa
stent graft system valiant captivia thorac aortic aneurysm taa
apv revenu increas compar
apv revenu increas
month period compar
strength divis driven mid-teen growth venou
reflect strong demand venas closur system mid-teen
growth drug-coat balloon high-singl digit growth thorac
stent graft system given continu launch valiant navion
group segment includ surgic innov si respiratori
gastrointestin renal divis si divis contribut
revenu divis contribut revenu
mitg revenu increas compar
increas constant currenc basi mitg
revenu driven strong perform divis high-singl
digit constant currenc growth mid-singl digit constant currenc
growth si
compar
compar
increas
mitg revenu
 increas
compar
mitg revenu increas
compar mitg revenu non-u
develop market increas compar
mitg revenu emerg market increas
compar
si revenu increas
compar
surgic innov si si divis develop manufactur market
product therapi treat diseas condit address
surgeon surgic innov busi includ sale stapl vessel
seal fixat hernia mechan devic mesh hardwar surgic
instrument sutur electro surgeri product
si revenu increas compar
si revenu increas
month period compar
increas driven low-doubl digit constant currenc growth
advanc result strength ligasur vessel
seal instrument innov nano-co valleylab
energi platform advanc stapl grew high-singl digit
constant currenc basi driven strong demand tri-stapl endo
stapl specialti reload signia power stapler
compar
compar
divis consist respiratori monitor solut
busi includ patient monitor respiratori solut advanc
ablat gi solut product line renal solut busi
includ renal access dialyz product line
revenu increas compar
revenu declin
month period compar
respiratori grew high-singl digit constant currenc basi
strength puritan bennett ventil mcgrath video
laryngoscop nellcor puls oximetri product renal solut
grew mid-teen constant currenc basi strength renal
access product bellco product line gi solut grew mid-singl
digit constant currenc basi led solid perform gi
restor therapi group rtg rtg includ spine brain therapi
specialti therapi pain therapi divis spine divis
contribut revenu brain therapi contribut revenu
specialti therapi contribut revenu pain therapi
contribut revenu
rtg revenu increas compar
rtg revenu increas
month period compar
rtg revenu decreas
compar rtg revenu non-u
develop market increas compar
rtg revenu emerg market increas
compar
rtg revenu driven low-doubl digit growth brain therapi mid-
singl digit growth pain therapi low-singl digit growth specialti
therapi flat result spine constant currenc basi
decreas
compar
increas
compar
spine divis develop manufactur market line medic
devic implant use treatment spine musculoskelet
system product therapi treat rang condit affect
fractur spine stenosi
spine divis also provid biolog solut orthoped
dental market concert surgic technolog busi
offer navig neuromonitor power technolog design
spine revenu decreas compar
spine revenu rel flat
period
global spine revenu spine revenu grew mid-
singl digit constant currenc basi posterior cervic grew mid-
teen constant currenc basi driven continu launch
brain therapi divis develop manufactur market product
therapi treat diseas vasculatur around brain
product includ coil neurovascular stent flow divers product
well access deliveri product support procedur product
offer includ pipelin pipelin flex embol devic
endovascular treatment larg giant wide-neck brain aneurysm
solitair fr revascular devic treatment acut ischem stroke
apollo onyx deliveri micro cathet
increas
compar
revenu increas
compar
brain therapi revenu increas
compar period brain
therapi revenu increas compar
increas driven high-teen constant currenc growth
neurovascular neurosurgeri neurovascular deliv mid-twenti
constant currenc growth stent retriev acut ischem stroke
strength solitair platinum
busi also double-digit growth constant currenc basi
neuro access flow divers embol product neurosurgeri led
strong capit equip sale stealthstat surgic navig
system mida power surgic instrument system
specialti divis develop manufactur market product
therapi treat diseas condit ear nose throat ent
certain neurolog disord
addit divis develop manufactur market image-guid
surgeri intra-op imag system facilit surgic plan
precis cranial spinal sinu orthoped surgeri
specialti therapi revenu increas
compar period specialti
therapi revenu increas compar
revenu led mid-teen constant currenc
growth transform solut strong sale aquamanti
pain therapi divis includ implant neurostimul
target drug deliveri system manag chronic pain
common movement disord spastic urolog gastrointestin
disord portfolio neurostimul system includ
recharg non-recharg devic select lead use
treat chronic back and/or limb pain
portfolio product includ pain neurostimul system
surescan includ restoresensor recharg
surescan mri adaptivestim technolog devic use
treat chronic intract pain sever spastic associ
cerebr palsi multipl sclerosi spinal cord traumat brain injuri
stroke
pain therapi revenu increas
compar pain therapi revenu increas
period compar
divis high-singl digit constant currenc growth pain
stimul continu strength intelli platform spinal
cord stimul divis also mid-singl digit constant currenc
growth intervent pain
diabet group divis develop manufactur market integr
diabet manag solut includ insulin pump therapi
continu glucos monitor cgm system therapi manag
softwar diabet group organ advanc insulin
manag aim emerg technolog divis
increas
compar
divis high-
currenc growth pain
stimul
continu strength
intelli platform
diabet group revenu increas
compar increas constant
currenc basi period total revenu increas
compar
despit face difficult comparison pump sale given backlog
patient order compani clear prior year
revenu grew mid-singl digit constant currenc driven
sustain global market demand minim hybrid close
loop insulin pump system guardian sensor
divis face difficult comparison versu prior year
grew mid-singl digit versu prior quarter report includ high-
singl digit growth insulin pump versu prior quarter report
global adopt sensor-aug insulin pump system
result strong sensor attach rate integr cgm sale
grow high-twenti constant currenc basi
revenu grew low-fifti constant currenc basi driven
on-going launch guardian connect cgm system sugar iq
person diabet assist grew tripl digit third
increas
compar
increas
constant
currenc driven
demand
system
revenu growth
rang
expect organ revenu growth rang
recent exchang rate hold remaind mdt
revenu would neg affect
ep rang
expect non-gaap ep rang
recent exchang rate hold remaind fiscal year foreign
exchang would modest posit impact mdt ep
expect free cash flow new rang
entranc
market global
launch
use provid
support access
revenu grew organ reflect
benefit diversifi model leverag top-lin grow adjust
oper profit adjust ep constant currenc basi
report basi
revenu out-performance mitg rtg driven number recent
product launch off-set challeng cvg big driver emerg
market grew reflect strong quarter across busi
mitg segment includ surgic innov si respiratori
gastrointestin renal divis mitg revenu increas
mitg revenu driven strong perform
divis high-singl digit constant currenc growth mid-singl
digit constant currenc growth si
rtg revenu increas rtg revenu driven
low-doubl digit growth brain therapi mid-singl digit growth pain
therapi low-singl digit growth specialti therapi flat result spine
constant currenc basi
diabet group revenu increas advanc
insulin manag revenu grew mid-singl digit constant currenc driven
sustain global market demand minim hybrid close loop
insulin pump system guardian sensor
emerg technolog revenu grew low-fifti constant currenc
basi driven on-going launch guardian connect cgm system
sugar iq person diabet assist grew tripl digit
plc announc entranc guid extens cathet market
global launch telescop tm guid extens cathet newli
design cathet use provid addit back-up support access
intervent devic angioplasti procedur help
restor blood flow coronari peripher arteri
non- reconcili
non- reconcili
non- reconcili
incom statement
non-
per share item
product perform develop
valuat consensu perform
gross margin increas ttm basi compar due decreas cog
oper margin increas ttm basi compar
net margin increas ttm basi compar due decreas tax rate
ep growth ttm basi compar
ratio revenu margin margin inc margin rate margin turnov averag asset leverag averag equiti year averag averag averag year averag averag averag year averag averag averag growth growth ex sale /sale /net incom ratio profit marginsprofitabilityrevenu growth oper incom growthep growth plc jun
mrqgross mrqoper mrqnet mrqcog mrqsg mrqr sale medtron plc jun
invest flow
sale
mrqyoy growth revenu growthoper incom growthep mrq ratio growth yoy oper growth yoy free growth mrqcapex salescap ex salesfre mrqfinanci mrqreturn mrqreturn asset medtron plc jun
per share item ratio
fiscal per ebitda per ebit per earn per share ep ep free flow per dividend per book valu per tangibl book per month end stock month end stock equiti return asset return invest capit return capit joel greenblatt debt gross margin oper margin net margin total equiti total lt debt total asset dividend pay-out day sale day account day convers inventori cog inventori tax rate net incom net incom discontinued- net net margin prefer dividends- annual itemsquarterli item medtron plc jun
balanc sheet item
outstand equival market debt common stock- prefer stock- purchas properti plant sale properti plant equipment- purchas sale business- purchas sale issuanc repurchas net issuanc prefer stock- net issuanc net chang capit free plc jun
current price-to-earnings averag price-to-earnings due increas stock price price-to-earnings
show huge fluctuat last three year due volatil stock price price-to-earnings trail
expect forward price-to-earnings
incom statement
non-
per share item
product perform develop
valuat consensu perform
breakdown share held share held float held institut hold institut holdersholdersharesd report outvaluevanguard group inc wellington manag compani massachusett servic lazard asset manag price row associ geod capit manag jp morgan top mutual fund holdersholdersharesd report outvaluevanguard total stock market vanguard spdr etf mf seri trust i-mf valu vanguard/windsor vanguard institut fund-institut vanguard/wellington fund vanguard specialized-health vanguard specialized-dividend appreci dodg cox stock plc jun
develop launch telescop tm guid extens cathet support complex coronari casesmay plc global leader percutan coronari intervent pci innov announc entranc guid extens cathet market global launch telescop tm guid extens cathet newli design cathet use provid addit back-up support access distal lesion guid extens cathet help deliv coronari stent balloon intervent devic angioplasti procedur help restor blood flow coronari peripher arteri enter definit agreement acquir titan spinemay plc global leader medic technolog announc enter definit agreement pursuant acquir titan spine privately-held titanium spine interbodi implant surfac technolog compani board director compani unanim approv transact term transact disclos announc commerci launch solitair tm revascular deviceapril plc announc launch solitair tm revascular devic first use patient treatment acut ischem stroke ten year industry-lead solitair tm revascular devic enabl physician help patient better chanc recov stroke solitair gener devic featur optim deliveri system improv effici retain technic featur made solitair famili revascular devic clinic proven highli effect addit introduc phenom tm cathet length microcathet deliveri size solitair launch med-tech innov acceler shanghaiapril plc global leader medic technolog announc launch med-tech innov acceler pujiang intern scienc technolog citi minhang district shanghai new collabor innov platform provid servic med-tech start-up world-wide address unmet clinic need china welcom initi roster portfolio compani new acceler commit empow early-stag med-tech innov aim improv patient outcom convert idea valuabl medic product solut plc jun
incom statement
non-
per share item
product perform develop
valuat consensu perform
compar
roa roi roe
actual vs price-to-earnings ratio ttm price-to-earnings high last yr price-to-earnings last yr beta price sale ttm price book mrq price ttm price free ttm errorerrorerror own dividend yield dividend yield year average dividend year growth rate pay-out ratio ttm sale mrq vs qtr yr sale ttm vs ttm yr sale yr growth rate sale yr growth rate ep mrq vs qtr yr ep ttm vs ttm yr ep yr growth rate ep yr growth rate capit spend yr growth rate lt debt equiti mrq total debt equiti mrq interest coverag ttm gross margin ttm gross margin yr average ebitd margin ttm ebitd yr average oper margin ttm oper margin yr average pre-tax margin ttm pre-tax margin yr average net profit margin ttm net profit margin yr average effect tax rate ttm effect tax rate yr average return asset ttm return asset yr average return invest ttm return invest yr average return equiti ttm return equiti yr average revenue/employe ttm net income/employe ttm receiv turnov ttm inventori turnov ttm asset turnov ttm manag effect effici performancevalu ratio dividend growth rate ratio profit plc jun
consensu view analyst trend stock
forecast
compar
forward price-to-earnings
compar
annual usdgrowth high day day day estim avgfive-year growth forecast comparisonmdtindustri avg avgprice/earn yield plc jun
consensu view analyst trend stock
averag earn estim
current qtr
next qtr
sale growth estim current
qtr next
qtr
averag revenu estim
current qtr
estimatescurr analyst estimatethi estim estimatepast ep growthprice/earningsobsoleteobsoleteobsoleteobsoletepeg ratioobsoleteobsoleteobsoleteobsoleteconsensu ep day day day day ep last last last dayserrorerrorerrorerrordown last dayscurr growth ratescurr surprisescurr analyst recommend
incom statement
non-
per share item
product perform develop
valuat consensu perform
stock price volatil quarter declin april
stock declin period averag volum share trade
stock price volatil past current trade
stock gave return past rang stock
stock price volatil surg novemb
stock gave return past dip decemb
deliv strong perform quarter growth revenu due strong growth
across mitg rtg segment emerg market non-gaap ep grew quarter
recommend buy rate stock tp base perform new
crispidea financi inform servic firm focus provid equiti research portfolio manag
person wealth manag brokerag servic inform servic side provid commun
consult research servic host ofclient
crispidea track limit number compani sector strive provid qualiti insight straight
forward analysi object creat long-term wealth moder low risk crispidea leverag
larg number in-hous extern expert oper within industri strong financi oper
strateg background
detail visit www crispidea com orcontact
